BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alshawsh MA, Alsalahi A, Alshehade SA, Saghir SAM, Ahmeda AF, Al Zarzour RH, Mahmoud AM. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet. Molecules 2022;27:858. [PMID: 35164140 DOI: 10.3390/molecules27030858] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Song Y, Li C, Luo Y, Guo J, Kang Y, Yin F, Ye L, Sun D, Yu J, Zhang X. CCN6 improves hepatic steatosis, inflammation, and fibrosis in non-alcoholic steatohepatitis. Liver Int 2023;43:357-69. [PMID: 36156376 DOI: 10.1111/liv.15430] [Reference Citation Analysis]
2 Zhen Q, Liang Q, Wang H, Zheng Y, Lu Z, Bian C, Zhao X, Guo X. Theabrownin ameliorates liver inflammation, oxidative stress, and fibrosis in MCD diet-fed C57BL/6J mice. Front Endocrinol 2023;14. [DOI: 10.3389/fendo.2023.1118925] [Reference Citation Analysis]
3 Akl MG, Widenmaier SB. Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma. Front Cell Dev Biol 2022;10:1089124. [PMID: 36712976 DOI: 10.3389/fcell.2022.1089124] [Reference Citation Analysis]
4 Alshehade SA, Al Zarzour RH, Mathai M, Giribabu N, Seyedan A, Kaur G, Al-Suede FSR, Majid AMSA, Murugaiyah V, Almoustafa H, Alshawsh MA. Orthosiphon aristatus (Blume) Miq Alleviates Non-Alcoholic Fatty Liver Disease via Antioxidant Activities in C57BL/6 Obese Mice and Palmitic-Oleic Acid-Induced Steatosis in HepG2 Cells. Pharmaceuticals (Basel) 2023;16. [PMID: 36678606 DOI: 10.3390/ph16010109] [Reference Citation Analysis]
5 Kamata S, Ishii I. 2D-DIGE Proteomic Analysis of Mouse Liver Within 1 Week. Methods in Molecular Biology 2023. [DOI: 10.1007/978-1-0716-2831-7_16] [Reference Citation Analysis]
6 Alshehade SA, Al Zarzour RH, Murugaiyah V, Lim SYM, El-refae HG, Alshawsh MA. Mechanism of action of Orthosiphon stamineus against non-alcoholic fatty liver disease: Insights from systems pharmacology and molecular docking approaches. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.09.001] [Reference Citation Analysis]
7 Skrypnik K, Olejnik-schmidt A, Mikołajczyk-stecyna J, Schmidt M, Suliburska J. Influence of supplementation of probiotic bacteria Lactobacillus plantarum and Lactobacillus curvatus on selected parameters of liver iron metabolism in rats on high-fat iron-deficient diet. Journal of Functional Foods 2022;96:105205. [DOI: 10.1016/j.jff.2022.105205] [Reference Citation Analysis]
8 Reis-Barbosa PH, Marinho TS, Matsuura C, Aguila MB, de Carvalho JJ, Mandarim-de-Lacerda CA. The obesity and nonalcoholic fatty liver disease mouse model revisited: Liver oxidative stress, hepatocyte apoptosis, and proliferation. Acta Histochem 2022;124:151937. [PMID: 35952484 DOI: 10.1016/j.acthis.2022.151937] [Reference Citation Analysis]
9 Alshehade S, Alshawsh MA, Murugaiyah V, Asif M, Alshehade O, Almoustafa H, Al Zarzour RH. The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions. Life Sci 2022;:120732. [PMID: 35760093 DOI: 10.1016/j.lfs.2022.120732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Palladini G, Di Pasqua LG, Cagna M, Croce AC, Perlini S, Mannucci B, Profumo A, Ferrigno A, Vairetti M. MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis. Int J Mol Sci 2022;23:6817. [PMID: 35743260 DOI: 10.3390/ijms23126817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]